Home › NDC Lookup › RxCUI directory › RxCUI 2398841

3 ML semaglutide 1.34 MG/ML Pen Injector — RxCUI 2398841

Name: 3 ML semaglutide 1.34 MG/ML Pen Injector (RxCUI 2398841)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2398841 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2398841

Official name3 ML semaglutide 1.34 MG/ML Pen Injector

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known assemaglutide 4 MG in 3 ML Pen Injector

FDA products mapped7

Package NDCs mapped6

Reported Medicaid activity (SDUD)3,651,150 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Semaglutide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's more than just a weight loss medication, though that's one of its main uses. Wegovy injection is approved to help reduce and maintain weight loss in adults with obesity or ove...
What exactly is this injection for — is it just a weight loss shot?
The most common side effects are stomach-related — nausea, diarrhea, vomiting, constipation, and stomach pain. These tend to be the worst when you first start or when your dose get...
What side effects should I expect, and when do they usually go away?

📖 Read our full Semaglutide Injection guide →

🕸️ Concept Web — How 3 ML semaglutide 1.34 MG/ML Pen Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 3 ML semaglutide 1.34 MG/ML Pen Injector RxCUI 2398841 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Semaglutide 1991302 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Ozempic 1991307 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Semaglutide Pen Injector 1991305 SCDF
- Semaglutide Injectable Product 1991304 SCDG
- Semaglutide Pen Injector [Ozempic] 1991309 SBDF
- Ozempic Injectable Product 1991310 SBDG
- Pen Injector 1649571 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Semaglutide 1.34 MG/ML 1991303 SCDC
- 3 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic] 2398842 SBD
- Semaglutide 1.34 MG/ML [Ozempic] 1991308 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Semaglutide 1.34 MG/ML SCDC · 1991303
Semaglutide Pen Injector SCDF · 1991305
Semaglutide Injectable Product SCDG · 1991304

Brand-Name Concepts

3 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic] SBD · 2398842
Semaglutide 1.34 MG/ML [Ozempic] SBDC · 1991308
Semaglutide Pen Injector [Ozempic] SBDF · 1991309
Ozempic Injectable Product SBDG · 1991310
Ozempic BN · 1991307

📦 FDA Products & Package NDCs

7 products · 6 package NDCs

6 package NDCs map to RxCUI 2398841 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00169-4130-13	1 SYRINGE, PLASTIC in 1 CARTON (0169-4130-13) / 3 mL in 1 S...	Ozempic	Novo Nordisk Pharmaceutical Industries, LP	2021-01-03
00169-4181-13	1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-13) / 3 mL in 1 S...	Ozempic	Novo Nordisk Pharmaceutical Industries, LP	2022-10-07
00169-4181-97	1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-97) / 3 mL in 1 S...	Ozempic	Novo Nordisk Pharmaceutical Industries, LP	2022-10-07
00169-4772-12	1 SYRINGE, PLASTIC in 1 CARTON (0169-4772-12) / 3 mL in 1 S...	Ozempic	Novo Nordisk Pharmaceutical Industries, LP	2022-04-25
00169-4772-97	1 SYRINGE, PLASTIC in 1 CARTON (0169-4772-97) / 3 mL in 1 S...	Ozempic	Novo Nordisk Pharmaceutical Industries, LP	2022-04-25
50090-5949-00	1 SYRINGE, PLASTIC in 1 CARTON (50090-5949-0) / 3 mL in 1 S...	Ozempic	A-S Medication Solutions	2022-04-01

Observed labelers: Novo Nordisk Pharmaceutical Industries, LP (5) · A-S Medication Solutions (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.